Nanoparticle delivery for metastatic breast cancer

Desantis, 2011, Breast cancer statistics 2011, CA Cancer J Clin, 10.3322/caac.20134 Gold, 2009, Chemotherapy for metastatic breast cancer, 1233 Carty, 1995, Patterns of clinical metastasis in breast cancer: an analysis of 100 patients, Eur J Surg Oncol, 21, 607, 10.1016/S0748-7983(95)95176-8 Noh, 2011, Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype, J Breast Cancer, 14, 46, 10.4048/jbc.2011.14.1.46 Tomiak, 1996, Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study, Eur J Cancer, 32A, 1876, 10.1016/0959-8049(96)00189-X Leong, 2011, The changing role of pathology in breast cancer diagnosis and treatment, Pathobiology, 78, 99, 10.1159/000292644 Davies, 2011, New therapeutic approaches in breast cancer, Maturitas, 68, 121, 10.1016/j.maturitas.2010.10.012 Cuenca, 2006, Emerging implications of nanotechnology on cancer diagnostics and therapeutics, Cancer, 107, 459, 10.1002/cncr.22035 Hahn, 2011, Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives, Anal Bioanal Chem, 399, 3, 10.1007/s00216-010-4207-5 Manthe, 2010, Tumor ablation and nanotechnology, Mol Pharm, 7, 1880, 10.1021/mp1001944 Wang, 2011, Nanoparticle delivery of cancer drugs, Annu Rev Med Sharma, 2010, Multimodal nanoparticulate bioimaging contrast agents, Methods Mol Biol, 624, 67, 10.1007/978-1-60761-609-2_5 Alexis, 2010, Nanoparticle technologies for cancer therapy, Handb Exp Pharmacol, 55, 10.1007/978-3-642-00477-3_2 Moghimi, 2012, Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective, Annu Rev Pharmacol Toxicol, 52, 481, 10.1146/annurev-pharmtox-010611-134623 Eroles, 2011, Molecular biology in breast cancer: intrinsic subtypes and signaling pathways, Cancer Treat Rev Rai, 2011, Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer, J Biomed Nanotechnol, 7, 121, 10.1166/jbn.2011.1231 Grobmyer, 2008, Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?, J Am Coll Surg, 206, 1045, 10.1016/j.jamcollsurg.2007.12.039 Yang, 2009, Receptor-targeted nanoparticles for in vivo imaging of breast cancer, Clin Cancer Res, 15, 4722, 10.1158/1078-0432.CCR-08-3289 Meier, 2010, Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133, Radiology, 255, 527, 10.1148/radiol.10090050 Hirsch, 2006, Metal nanoshells, Ann Biomed Eng, 34, 15, 10.1007/s10439-005-9001-8 Lowery, 2006, Immunonanoshells for targeted photothermal ablation of tumor cells, Int J Nanomed, 1, 149, 10.2147/nano.2006.1.2.149 O'Neal, 2004, Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles, Cancer Lett, 209, 171, 10.1016/j.canlet.2004.02.004 Bardhan, 2010, Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo, Nano Lett, 10.1021/nl102889y Gaitanis, 2010, Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use, Methods Mol Biol, 624, 385, 10.1007/978-1-60761-609-2_26 Gradishar, 2009, Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer, J Clin Oncol, 27, 3611, 10.1200/JCO.2008.18.5397 Desai, 2008, Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status, Anticancer Drugs, 19, 899, 10.1097/CAD.0b013e32830f9046 Karmali, 2009, Targeting of albumin-embedded paclitaxel nanoparticles to tumors, Nanomed Nanotechnol Biol Med, 5, 73, 10.1016/j.nano.2008.07.007 Moura, 2011, Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer, Breast Cancer Res Treat Murphy, 2011, Targeted nanogels: a versatile platform for drug delivery to tumors, Mol Cancer Ther, 10, 972, 10.1158/1535-7163.MCT-10-0729 Brown, 2010, Nanoparticle characterization for cancer nanotechnology and other biological applications, Methods Mol Biol, 624, 39, 10.1007/978-1-60761-609-2_4 Sonavane, 2008, Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size, Colloids Surf B Biointerfaces, 66, 274, 10.1016/j.colsurfb.2008.07.004 Powers, 2006, Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation, Toxicol Sci, 90, 296, 10.1093/toxsci/kfj099 Arruebo, 2009, Antibody-conjugated nanoparticles for biomedical applications, J Nanomater, 2009, 1, 10.1155/2009/439389 Nobs, 2004, Current methods for attaching targeting ligands to liposomes and nanoparticles, J Pharm Sci, 93, 1980, 10.1002/jps.20098 Melancon, 2008, In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy, Mol Cancer Ther, 7, 1730, 10.1158/1535-7163.MCT-08-0016 Pathak, 2007, Characterization of the functional binding properties of antibody conjugated quantum dots, Nano Lett, 7, 1839, 10.1021/nl062706i Choi, 2010, Design considerations for tumour-targeted nanoparticles, Nat Nanotechnol, 5, 42, 10.1038/nnano.2009.314 Schmidt, 2009, A modeling analysis of the effects of molecular size and binding affinity on tumor targeting, Mol Cancer Ther, 8, 2861, 10.1158/1535-7163.MCT-09-0195 Park, 2009, Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting, Small, 5, 694, 10.1002/smll.200801789 Kirpotin, 2006, Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models, Cancer Res, 66, 6732, 10.1158/0008-5472.CAN-05-4199 D'Angelo-Donovan, 2012, Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations, Surg Oncol, 10.1016/j.suronc.2011.12.005 Krag, 1998, The sentinel node in breast cancer—a multicenter validation study, N Engl J Med, 339, 941, 10.1056/NEJM199810013391401 Howard, 2012, Current management and treatment strategies for breast cancer, Curr Opin Obstet Gynecol, 24, 44, 10.1097/GCO.0b013e32834da4b1 Kim, 2004, Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping, Nat Biotechnol, 22, 93, 10.1038/nbt920 Hama, 2007, Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity, Breast Cancer Res Treat, 103, 23, 10.1007/s10549-006-9347-0 Robe, 2008, Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice, BMC Cancer, 8, 111, 10.1186/1471-2407-8-111 Takeda, 2008, In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine, Breast Cancer, 15, 145, 10.1007/s12282-008-0037-0 Erogbogbo, 2011, In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals, ACS Nano, 5, 413, 10.1021/nn1018945 Ballou, 2007, Sentinel lymph node imaging using quantum dots in mouse tumor models, Bioconjug Chem, 18, 389, 10.1021/bc060261j Pan, 2010, Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons, Biomaterials, 31, 4088, 10.1016/j.biomaterials.2010.01.136 Tafreshi, 2011, A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes, Cancer Res, 71, 1050, 10.1158/0008-5472.CAN-10-3091 Tafreshi, 2012, Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes, Clin Cancer Res, 18, 207, 10.1158/1078-0432.CCR-11-0238 Mundy, 2002, Metastasis to bone: causes, consequences and therapeutic opportunities, Nat Rev Cancer, 2, 584, 10.1038/nrc867 Clezardin, 2011, Therapeutic targets for bone metastases in breast cancer, Breast Cancer Res, 13, 207, 10.1186/bcr2835 Hussein, 2011, Breast cancer at bone metastatic sites: recent discoveries and treatment targets, J Cell Commun Signal, 5, 85, 10.1007/s12079-011-0117-3 Mann, 2011, E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow, Adv Mater, 23, H278, 10.1002/adma.201101541 Elazar, 2010, Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis, Int J Cancer, 126, 1749 Tsukada, 1983, Central nervous system metastasis from breast carcinoma. Autopsy study, Cancer, 52, 2349, 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B Wadasadawala, 2007, Brain metastases from breast cancer: management approach, J Cancer Res Ther, 3, 157, 10.4103/0973-1482.37409 Kievit, 2011, Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers, Adv Mater, 23, H217, 10.1002/adma.201102313 Costantino, 2011, Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?, Drug Discov Today Bednarz-Knoll, 2011, Clinical relevance and biology of circulating tumor cells, Breast Cancer Res, 13, 228, 10.1186/bcr2940 Pantel, 2009, Cancer micrometastases, Nat Rev Clin Oncol, 6, 339, 10.1038/nrclinonc.2009.44 Zharov, 2006, In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents, Opt Lett, 31, 3623, 10.1364/OL.31.003623 Galanzha, 2009, Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in vivo detection and killing of circulating cancer stem cells, J Biophotonics, 2, 725, 10.1002/jbio.200910078 Galanzha, 2009, In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells, Nat Nanotechnol, 4, 855, 10.1038/nnano.2009.333 Galanzha, 2009, In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser, Cancer Res, 69, 7926, 10.1158/0008-5472.CAN-08-4900 Hughes, 2011, Nanobiotechnology for the capture and manipulation of circulating tumor cells, Wiley Interdiscip Rev Nanomed Nanobiotechnol Proskurnin, 2011, In vivo multispectral photoacoustic and photothermal flow cytometry with multicolor dyes: a potential for real-time assessment of circulation, dye-cell interaction, and blood volume, Cytometry A, 79, 834, 10.1002/cyto.a.21127 Choi, 2007, A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors, Nano Lett, 7, 3759, 10.1021/nl072209h Kennedy, 2011, T cells enhance gold nanoparticle delivery to tumors in vivo, Nanoscale Res Lett, 6, 283, 10.1186/1556-276X-6-283 Kelly, 1988, Macrophages in human breast disease: a quantitative immunohistochemical study, Br J Cancer, 57, 174, 10.1038/bjc.1988.36 Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005 Lin, 2001, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J Exp Med, 193, 727, 10.1084/jem.193.6.727 Hagemann, 2004, Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases, Carcinogenesis, 25, 1543, 10.1093/carcin/bgh146 Studeny, 2002, Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors, Cancer Res, 62, 3603 Loebinger, 2009, Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles, Cancer Res, 69, 8862, 10.1158/0008-5472.CAN-09-1912 Cole, 2005, Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells, Nat Med, 11, 1073, 10.1038/nm1297 Rai, 2008, Targeted delivery of doxorubicin via estrone-appended liposomes, Journal of drug targeting, 16, 455, 10.1080/10611860802088481 Dreaden, 2009, Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment, Bioconjug Chem, 20, 2247, 10.1021/bc9002212 Liu, 2010, Targeted cancer therapy with novel high drug-loading nanocrystals, J Pharm Sci, 99, 3542, 10.1002/jps.22112 Pan, 2009, Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers, Biomaterials, 30, 1176, 10.1016/j.biomaterials.2008.10.039 Tada, 2007, In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice, Cancer Res, 67, 1138, 10.1158/0008-5472.CAN-06-1185 Loo, 2005, Immunotargeted nanoshells for integrated cancer imaging and therapy, Nano Lett, 5, 709, 10.1021/nl050127s Koopaei, 2011, Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies, Int J Nanomed, 6, 1903 Day, 2010, Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer, Int J Nanomed, 5, 445, 10.2147/IJN.S10881 Puri, 2008, HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents, J Liposome Res, 18, 293, 10.1080/08982100802457377 Anhorn, 2008, Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles, Bioconjug Chem, 19, 2321, 10.1021/bc8002452 Zhang, 2011, Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia, Int J Hyperthermia, 27, 682, 10.3109/02656736.2011.609863 Yousefpour, 2011, Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab, Int J Nanomed, 6, 1977 Wu, 2008, Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles, J Nanosci Nanotechnol, 8, 2483, 10.1166/jnn.2008.362 Milane, 2011, Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells, Mol Pharm, 8, 185, 10.1021/mp1002653 Acharya, 2009, Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy, Biomaterials, 30, 5737, 10.1016/j.biomaterials.2009.07.008 Mulik, 2010, Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis, Int J Pharm, 398, 190, 10.1016/j.ijpharm.2010.07.021 Barth, 2010, Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo, ACS Nano, 4, 1279, 10.1021/nn901297q Zheng, 2010, Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells, Int J Pharm, 390, 234, 10.1016/j.ijpharm.2010.02.008 Soman, 2009, Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth, J Clin Investig, 119, 2830, 10.1172/JCI38842 Deng, 2011, Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy, Biomaterials, 32, 4976, 10.1016/j.biomaterials.2011.03.050 Yu, 2010, Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature, Biomaterials, 31, 2278, 10.1016/j.biomaterials.2009.11.047 Passarella, 2010, Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors, Cancer Res, 70, 4550, 10.1158/0008-5472.CAN-10-0339 Leuschner, 2006, LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases, Breast Cancer Res Treat, 99, 163, 10.1007/s10549-006-9199-7 Talaei, 2011, Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells, Int J Nanomed, 6, 1963 Zhou, 2006, Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases, Biomaterials, 27, 2001, 10.1016/j.biomaterials.2005.10.013 Pan, 2008, Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles, Biomaterials, 29, 2663, 10.1016/j.biomaterials.2008.02.020